ProShares Ultra Nasdaq Biotechnology (BIB)
BIB is a passive ETF by ProShares tracking the investment results of the NASDAQ Biotechnology Index (200%). BIB launched on Apr 7, 2010 and has a 0.95% expense ratio.
ETF Info
ISIN | US74347R2141 |
---|---|
CUSIP | 74347R214 |
Issuer | ProShares |
Inception Date | Apr 7, 2010 |
Region | North America (U.S.) |
Category | Leveraged Equities, Leveraged |
Leveraged | 2x |
Index Tracked | NASDAQ Biotechnology Index (200%) |
Home Page | www.proshares.com |
Asset Class | Equity |
Asset Class Size | Multi-Cap |
Asset Class Style | Growth |
Expense Ratio
The ProShares Ultra Nasdaq Biotechnology has a high expense ratio of 0.95%, indicating higher-than-average management fees.
Share Price Chart
Loading data...
Compare to other instruments
Popular comparisons: BIB vs. XBI, BIB vs. BIS, BIB vs. IBBQ, BIB vs. ARKG, BIB vs. BBH, BIB vs. SPY, BIB vs. AMGN, BIB vs. LABU
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in ProShares Ultra Nasdaq Biotechnology, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
ProShares Ultra Nasdaq Biotechnology had a return of 1.90% year-to-date (YTD) and 11.38% in the last 12 months. Over the past 10 years, ProShares Ultra Nasdaq Biotechnology had an annualized return of 4.44%, while the S&P 500 had an annualized return of 10.96%, indicating that ProShares Ultra Nasdaq Biotechnology did not perform as well as the benchmark.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | 1.90% | 10.04% |
1 month | -4.10% | 3.53% |
6 months | 19.43% | 22.79% |
1 year | 11.38% | 32.16% |
5 years (annualized) | 0.96% | 13.15% |
10 years (annualized) | 4.44% | 10.96% |
Monthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | 0.11% | 1.21% | ||||||||||
2023 | -1.25% | -8.35% | -13.34% | 9.12% | 25.86% |
Risk-Adjusted Performance
Risk-Adjusted Performance Indicators
This table presents risk-adjusted performance metrics for ProShares Ultra Nasdaq Biotechnology (BIB) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
---|---|---|---|---|---|
ProShares Ultra Nasdaq Biotechnology | 0.35 | ||||
S&P 500 | 2.76 |
Dividends
Dividend History
ProShares Ultra Nasdaq Biotechnology granted a 0.14% dividend yield in the last twelve months. The annual payout for that period amounted to $0.08 per share.
Period | TTM | 2023 | 2022 |
---|---|---|---|
Dividend | $0.08 | $0.04 | $0.02 |
Dividend yield | 0.14% | 0.07% | 0.03% |
Monthly Dividends
The table displays the monthly dividend distributions for ProShares Ultra Nasdaq Biotechnology. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | $0.00 | $0.00 | ||||||||||
2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.04 |
2022 | $0.02 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the ProShares Ultra Nasdaq Biotechnology. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the ProShares Ultra Nasdaq Biotechnology was 67.24%, occurring on Jun 27, 2016. Recovery took 1152 trading sessions.
The current ProShares Ultra Nasdaq Biotechnology drawdown is 47.81%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-67.24% | Jul 21, 2015 | 237 | Jun 27, 2016 | 1152 | Jan 25, 2021 | 1389 |
-64.76% | Feb 9, 2021 | 339 | Jun 13, 2022 | — | — | — |
-41.45% | May 13, 2011 | 60 | Aug 8, 2011 | 112 | Jan 18, 2012 | 172 |
-39.01% | Feb 26, 2014 | 33 | Apr 11, 2014 | 114 | Sep 24, 2014 | 147 |
-36.3% | Apr 16, 2010 | 48 | Jul 1, 2010 | 93 | Dec 17, 2010 | 141 |
Volatility
Volatility Chart
The current ProShares Ultra Nasdaq Biotechnology volatility is 9.64%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.